The higher dose is an option for those who need additional support, not a mandatory step
The two important incretin hormones are GLP-1 and GIP
United States
Rather than acting as a sedative, it is investigated as a regulatory signal within the neural circuits that govern sleep stage transitions
The NICE criteria are as follows: NICE recommends GLP-1 analogues or Tirzepatide (Mounjaro) for the treatment of adults with type 2 diabetes alongside diet and exercise when diabetes is insufficiently controlled, only if: triple therapy with metformin and 2 other oral antidiabetic drugs is ineffective, not tolerated or contraindicated, and a person has a body mass index (BMI) of 35 kg/m2 or more, and specific psychological or other medical problems associated with obesity, or a person has a BMI of less than 35 kg/m2, and: Insulin therapy would have significant occupational implications, or Weight loss would benefit other significant obesity-related complications
Additionally, the previously mentioned methods of consumption can all be ingested intravenously via regular nutrient IV treatments